May 10, 2017 / 5:10 PM / 3 months ago

BRIEF-Onxeo announces allowance of U.S. patent for Livatag in hepatocellular carcinoma

May 10 (Reuters) - ONXEO SA

* ONXEO ANNOUNCES ALLOWANCE OF U.S. PATENT FOR LIVATAG® IN HEPATOCELLULAR CARCINOMA

* USPTO NOTICE OF ALLOWANCE RECEIVED FOR PATENT RELATED TO SPECIFIC ROUTE OF ADMINISTRATION FOR LIVATAG PROVIDES PROTECTION OF RELATED CLAIMS UNTIL 2032 SOURCE TEXT FOR EIKON: FURTHER COMPANY COVERAGE: (Gdynia Newsroom:)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below